Kory James Wentworth insider trades: Entrada Therapeutics (TRDA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kory reports to the SEC
Open-market buys and sales
30 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | TRDA | ↓ Sell | 2,500 | $12.95 | $32K | Direct | Apr 2, 2026 (1d) |
| Mar 4, 2026 | TRDA | ↓ Sell | 7,988 | $12.25 | $98K | Direct | Mar 6, 2026 (2d) |
| Nov 21, 2025 | TRDA | ↓ Sell | 8,910 | $9.98 | $89K | Direct | Nov 24, 2025 (3d) |
| Mar 17, 2025 | TRDA | ↓ Sell | 1,784 | $10.67 | $19K | Direct | Mar 19, 2025 (2d) |
| Dec 2, 2024 | TRDA | ↓ Sell | 6,000 | $19.99 | $120K | Direct | Dec 3, 2024 (1d) |
| Nov 11, 2024 | TRDA | ↓ Sell | 8,637 | $19.98 | $173K | Direct | Nov 13, 2024 (2d) |
| Sep 9, 2024 | TRDA | ↓ Sell | 3,195 | $14.97 | $48K | Direct | Sep 10, 2024 (1d) |
| Jul 8, 2024 | TRDA | ↓ Sell | 1,758 | $14.95 | $26K | Direct | Jul 10, 2024 (2d) |
| Mar 6, 2024 | TRDA | ↓ Sell | 4,086 | $12.31 | $50K | Direct | Mar 8, 2024 (2d) |
| Dec 26, 2023 | TRDA | ↓ Sell | 12,500 | $15.59 | $195K | Direct | Dec 26, 2023 (0d) |
| Sep 6, 2023 | TRDA | ↓ Sell | 950 | $13.48 | $13K | Direct | Sep 6, 2023 (0d) |
| Jul 11, 2023 | TRDA | ↓ Sell | 10,000 | $17.99 | $180K | Direct | Jul 12, 2023 (1d) |
| Jun 21, 2023 | TRDA | ↓ Sell | 17,500 | $15.01 | $263K | Direct | Jun 23, 2023 (2d) |
| Mar 2, 2023 | TRDA | ↓ Sell | 1,747 | $10.53 | $18K | Direct | Mar 3, 2023 (1d) |
| Dec 8, 2022 | TRDA | ↓ Sell | 4,550 | $18.95 | $86K | Direct | Dec 12, 2022 (4d) |
| Dec 5, 2022 | TRDA | ↓ Sell | 3,110 | $18.19 | $57K | Direct | Dec 6, 2022 (1d) |
| Nov 16, 2022 | TRDA | ↓ Sell | 200 | $18.10 | $4K | Direct | Nov 18, 2022 (2d) |
| Aug 25, 2022 | TRDA | ↓ Sell | 4,669 | $13.78 | $64K | Direct | Aug 26, 2022 (1d) |
| Aug 23, 2022 | TRDA | ↓ Sell | 11,655 | $13.08 | $152K | Direct | Aug 23, 2022 (0d) |
| Aug 18, 2022 | TRDA | ↓ Sell | 600 | $13.02 | $8K | Direct | Aug 18, 2022 (0d) |
| Aug 3, 2020 | BLUE | ↓ Sell | 82 | $61.00 | $5K | Direct | Aug 5, 2020 (2d) |
| Jul 20, 2020 | BLUE | ↓ Sell | 596 | $66.38 | $40K | Direct | Jul 22, 2020 (2d) |
| Jun 4, 2020 | BLUE | ↓ Sell | 154 | $65.23 | $10K | Direct | Jun 8, 2020 (4d) |
| Jan 7, 2020 | BLUE | ↓ Sell | 223 | $89.97 | $20K | Direct | Jan 9, 2020 (2d) |
| Dec 19, 2019 | BLUE | ↓ Sell | 397 | $92.59 | $37K | Direct | Dec 23, 2019 (4d) |
| Jun 5, 2019 | BLUE | ↓ Sell | 61 | $127.60 | $8K | Direct | Jun 7, 2019 (2d) |
| Feb 28, 2019 | BLUE | ↓ Sell | 51 | $151.71 | $8K | Direct | Mar 4, 2019 (4d) |
| Feb 25, 2019 | BLUE | ↓ Sell | 208 | $150.00 | $31K | Direct | Feb 27, 2019 (2d) |
| Jan 28, 2019 | BLUE | ↓ Sell | 209 | $125.96 | $26K | Direct | Jan 30, 2019 (2d) |
| Dec 19, 2018 | BLUE | ↓ Sell | 388 | $103.05 | $40K | Direct | Dec 21, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TRDA insiders
Open-market trades in the last 12 months
About Kory James Wentworth's insider trades
Kory James Wentworth is Chief Financial Officer at Entrada Therapeutics (TRDA). Since Dec 19, 2018, Kory has reported no open-market purchases and 30 sales worth $1.9M on SEC Form 4. In the last 12 months: 3 sales ($219K).
Their filings also include option exercises (14 filings), grants and awards (13 filings), shares withheld for taxes (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TRDA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.